Hyperliquid Strategies
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 2 days.
- Recent price momentum is -25.8% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 9.0% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-21 20:27 UTC
Data coverage: 4 of 6 factors. Missing data is not a zero score.
The radar needs all six factors. Available grades are shown below.
Valuation D+
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 2.5x | Better than 99% |
| Forward P/E | 66.1x | Better than 5% |
| Price / Sales | 254.8x | Better than 2% |
| P/E vs own 5-yr range | 98th pctl | Better than 5% |
Growth N/A
How fast revenue, profit and free cash flow are compounding.
Not enough data to grade this factor.
Profitability A-
How much profit the business keeps from each dollar of sales and capital.
| Operating margin | -47.5% | Better than 9% |
| Net margin | 2,708.1% | Better than 100% |
| Return on equity | 27.4% | Better than 86% |
| Return on invested capital | 27.2% | Better than 95% |
Momentum C-
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -29.3% | Better than 19% |
| 6-month return | -2.5% | Better than 51% |
| Distance below 52-week high | 49.3% | Better than 19% |
Financial Health N/A
Balance-sheet strength: leverage, liquidity and interest coverage.
Not enough data to grade this factor.
Analyst View A+
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 100.0% | Better than 77% |
| Upside to average target | 200.8% | Better than 94% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 8.40
- Open
- 8.17
- Day range
- 7.38 - 8.27
- Avg price
- 7.69
- Volume
- 19.38M
- Turnover
- 148.94M
- Turnover ratei
- 9.81%
- Volume ratioi
- 1.28
- Amplitudei
- 10.63%
- 52-week rangei
- 3.01 - 14.76
Valuation
- P/Ei
- 5.86
- P/E (TTM)i
- 2.48
- P/Bi
- 0.61
- EPSi
- 1.28
- Book value / shi
- 12.29
- Net profit
- 353.74M
- Net assets
- 3.40B
Share structure
- Market cap
- 2.07B
- Float capi
- 1.48B
- Shares out
- 277.01M
- Float sharesi
- 197.55M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
49.3% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-55.91M net over the window
Short interest
- Shares short
- 24.94M
- % of floati
- 8.96%
- Days to coveri
- 1.51
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Hyperliquid Strategies (PURR)?
Hyperliquid Strategies last traded at 7.48. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Hyperliquid Strategies's market cap?
About 2.07B.
What is the P/E ratio of Hyperliquid Strategies?
The trailing twelve-month P/E is 2.48. The Valuation tab shows it against the stock's own five-year range.
Does Hyperliquid Strategies pay a dividend?
Hyperliquid Strategies does not currently pay a regular dividend.
Is Hyperliquid Strategies a buy according to analysts?
The consensus of 4 analysts is a Buy rating, with an average 12-month price target of 22.50, which implies 200.8% upside from the current price. This is not investment advice.
What is Hyperliquid Strategies's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Hyperliquid Strategies a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-11-20 19:59:51 · For reference only, not investment advice and not tailored to your situation.
Hyperliquid Strategies discussion 0 comments